RXDX

Prometheus Biosciences, Inc. Common Stock

Delisted

RXDX was delisted on the 15th of June, 2023.

51 hedge funds and large institutions have $573M invested in Prometheus Biosciences, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$4.02M
2 +$3.5M
3 +$2.53M
4
State Street
State Street
Massachusetts
+$983K
5
Wells Fargo
Wells Fargo
California
+$365K

Top Sellers

1 -$3.44M
2 -$2.65M
3 -$1.07M
4
Citadel Advisors
Citadel Advisors
Florida
-$944K
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$657K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$85.1M
2
$78.6M
3
$77.4M
4
$67.9M
5
$43.8M
6
$43.8M
7
$22.3M
8
$17.5M
9
$14.5M
10
$13.2M
11
$12.9M
12
$11.9M
13
$11.4M
14
$9.29M
15
$8.23M
16
$7.14M
17
$5.93M
18
$5.1M
19
$4.92M
20
$4.74M
21
$4.74M
22
$4.68M
23
$4.02M
24
$4M
25
$2.4M